Saturday 31, Dec 2011
Diabetes risk increase with inhaled steroids
Inhaling corticosteroids can elevate chances of being diagnosed with type 2 diabetes, according to investigators from the Jewish General Hospital’s Lady Davis Institute for Medical Research (LDI) in Montreal.
The investigators’ findings suggested that asthmatics and those suffering from chronic obstructive pulmonary disorder (COPD) taking corticosteroids may be at a considerable risk.
From Healthjockey.com:
Dr. Samy Suissa, Director of the Centre for Clinical Epidemiology at the LDI, and lead investigator, highlighted, “These are not insubstantial numbers. Over a large population the absolute numbers of affected people are significant. We recommend that physicians reserve the use of inhaled steroids for the patients who truly benefit from these medications, namely asthmatics, and curb their use in COPD to the few patients for whom they are indicated. In all cases, patients using high doses should be assessed for possible hyperglycemia and the lowest effective dose targeted.”
The study was published in the American Journal of Medicine.
Tags: COPD, corticosteroids, Inhaled steroids
Posted in buy steroids, Steroid Cycles, steroid nation, Steroids and Anabolic Steroids
The use of corticosteroids is effective for reducing the morbidity and mortality of severe bacterial pneumonia, Dr. Antoni Torres said at the 12th International Congress on Infectious Diseases.
In a large 12-month randomized trial, Roflumilast was found effective for improving lung function and prevent exacerbations in patients with COPD with chronic bronchitis and severe airflow obstruction.
Significant reductions in mortality rate can be noticed in COPD (chronic obstructive pulmonary disease) patients when inhaled
According to a study appearing in an issue of CHEST, the peer-reviewed journal of the
A potential form of treatment in context of one of the most common and fatal diseases in the UK – smokers lung – is about to be identified by scientists from the
Reduced mortality risk can be noticed in patients afflicted with chronic obstructive pulmonary disease (COPD) when they are treated with inhaled
According to Lung disease experts at Johns Hopkins, physicians treating their patients afflicted with COPD (chronic obstructive pulmonary disease) need to observe extra caution while dealing with them.
Chronic obstructive pulmonary disease (COPD), which is one of the five leading causes of death worldwide, is characterized by an inflammatory response to inhaled fumes such as tobacco smoke that results in breath shortness, limited airflow, and loss of lung function.
Patients afflicted with chronic obstructive pulmonary disease or COPD can be effectively treated and experienced reduced mortality risk when treated with inhaled corticosteroids, as per a study appearing in the CHEST, which is a peer-reviewed journal of the